Condition
Refractory High Risk Myelodysplastic Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Refractory High Risk Myelodysplastic Syndrome clinical trials that are recruiting, in United States. By phase: Phase 1/2 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Refractory High Risk Myelodysplastic Syndrome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining cladribine, idarubicin, cytarabine, and quizartinib for treating acute myeloid leukemia and high-risk myelodysplastic syndrome | Phase 1/2 | Houston, Texas | Recruiting | Aug 7, 2019 |
| Using CPX-351 to treat patients with high-risk blood cancers | Phase 1 | Houston, Texas | Recruiting | Mar 29, 2019 |
| Combining azacitidine and enasidenib for treating IDH2-mutant myelodysplastic syndrome | Phase 2 | Baltimore, Maryland and 2 other locations | Recruiting | Dec 26, 2017 |
All recruiting trials (3)
-
Combining cladribine, idarubicin, cytarabine, and quizartinib for treating acute myeloid leukemia and high-risk myelodysplastic syndrome
This study is testing a new combination of four drugs to see if it can help people with acute myeloid leukemia or high-risk myelodysplastic syndrome live longer and feel better.
-
Using CPX-351 to treat patients with high-risk blood cancers
This study is testing a new treatment called CPX-351 to see if it can safely help people with high-risk blood cancers like myelodysplastic syndrome or chronic myelomonocytic leukemia.
-
Combining azacitidine and enasidenib for treating IDH2-mutant myelodysplastic syndrome
This study is testing if combining two medications, azacitidine and enasidenib, can help people with IDH2-mutant myelodysplastic syndrome feel better and live longer.
Related topics
Quick answers
How many Refractory High Risk Myelodysplastic Syndrome clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.